272 related articles for article (PubMed ID: 32102350)
1. Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma.
Kim EL; Sorokin M; Kantelhardt SR; Kalasauskas D; Sprang B; Fauss J; Ringel F; Garazha A; Albert E; Gaifullin N; Hartmann C; Naumann N; Bikar SE; Giese A; Buzdin A
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32102350
[No Abstract] [Full Text] [Related]
2. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
Knudsen AM; Halle B; Cédile O; Burton M; Baun C; Thisgaard H; Anand A; Hubert C; Thomassen M; Michaelsen SR; Olsen BB; Dahlrot RH; Bjerkvig R; Lathia JD; Kristensen BW
Neuro Oncol; 2022 Jul; 24(7):1074-1087. PubMed ID: 34964899
[TBL] [Abstract][Full Text] [Related]
4. Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas.
Yang C; Tan Y; Li S; Zhou J; Wang Q; Wang Y; Xie Y; Chen L; Li J; Fang C; Kang C
Aging (Albany NY); 2019 Dec; 11(23):11224-11243. PubMed ID: 31822636
[TBL] [Abstract][Full Text] [Related]
5. Case of multifocal glioblastoma with four fusion transcripts of
Samii A; Sorokin M; Kar S; Makovskaia L; Garazha A; Hartmann C; Moisseev A; Kim E; Giese A; Buzdin A
Cold Spring Harb Mol Case Stud; 2021 Aug; 7(4):. PubMed ID: 34341009
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
[TBL] [Abstract][Full Text] [Related]
7. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
[TBL] [Abstract][Full Text] [Related]
8. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Glioblastomas Exhibit Higher Expression of Biomarkers with Stem-like Properties.
Nandeesh BN; Naskar S; Shashtri AH; Arivazhagan A; Santosh V
J Neurosci Rural Pract; 2018; 9(1):86-91. PubMed ID: 29456350
[TBL] [Abstract][Full Text] [Related]
10. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
[No Abstract] [Full Text] [Related]
11. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
13. EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.
Cominelli M; Grisanti S; Mazzoleni S; Branca C; Buttolo L; Furlan D; Liserre B; Bonetti MF; Medicina D; Pellegrini V; Buglione M; Liserre R; Pellegatta S; Finocchiaro G; Dalerba P; Facchetti F; Pizzi M; Galli R; Poliani PL
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25739547
[TBL] [Abstract][Full Text] [Related]
14. Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.
Drexler R; Khatri R; Schüller U; Eckhardt A; Ryba A; Sauvigny T; Dührsen L; Mohme M; Ricklefs T; Bode H; Hausmann F; Huber TB; Bonn S; Voß H; Neumann JE; Silverbush D; Hovestadt V; Suvà ML; Lamszus K; Gempt J; Westphal M; Heiland DH; Hänzelmann S; Ricklefs FL
Acta Neuropathol; 2024 Jan; 147(1):21. PubMed ID: 38244080
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive profile of recurrent glioblastoma.
Campos B; Olsen LR; Urup T; Poulsen HS
Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
[TBL] [Abstract][Full Text] [Related]
17. From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response.
Gallaher JA; Massey SC; Hawkins-Daarud A; Noticewala SS; Rockne RC; Johnston SK; Gonzalez-Cuyar L; Juliano J; Gil O; Swanson KR; Canoll P; Anderson ARA
PLoS Comput Biol; 2020 Feb; 16(2):e1007672. PubMed ID: 32101537
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of glioblastomas: does location matter?
Denicolaï E; Tabouret E; Colin C; Metellus P; Nanni I; Boucard C; Tchoghandjian A; Meyronet D; Baeza-Kallee N; Chinot O; Figarella-Branger D
Oncotarget; 2016 Jan; 7(1):902-13. PubMed ID: 26637806
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.
Buehler M; Yi X; Ge W; Blattmann P; Rushing E; Reifenberger G; Felsberg J; Yeh C; Corn JE; Regli L; Zhang J; Cloos A; Ravi VM; Wiestler B; Heiland DH; Aebersold R; Weller M; Guo T; Weiss T
Neuro Oncol; 2023 Feb; 25(2):290-302. PubMed ID: 35802605
[TBL] [Abstract][Full Text] [Related]
20. Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.
Orzan F; De Bacco F; Crisafulli G; Pellegatta S; Mussolin B; Siravegna G; D'Ambrosio A; Comoglio PM; Finocchiaro G; Boccaccio C
Stem Cells; 2017 Nov; 35(11):2218-2228. PubMed ID: 28895245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
